Cellular specificity is key to deciphering epigenetic changes underlying Alzheimer's disease

Area of Science:

• Neuroscience
• Genetics
• Epigenetics

Background:

• Alzheimer's disease (AD) involves complex genetic and environmental factors.
• Late-onset AD (LOAD) risk loci are often in non-coding genome regions.
• Epigenetics, particularly cell-type specific epigenomes, can explain these factors.

Purpose of the Study:

• To review cell-type specific genome-wide profiling in LOAD.
• To highlight epigenetic mechanisms in AD progression.
• To address limitations of bulk-tissue studies.

Main Methods:

• Review of studies profiling DNA methylation (CpG, CpH, hydroxymethylation).
• Analysis of histone modifications and chromatin changes.
• Focus on cell-type specific epigenome profiling.

Main Results:

• Distinct brain cell types exhibit unique epigenetic alterations in AD.
• These cell-specific changes differ in their contribution and reaction to AD progression.
• Epigenetic modifications are dynamic and cell-specific.

Conclusions:

• Cell-type specific epigenetic profiling is critical for understanding LOAD.
• Understanding these specific changes is key to developing effective AD treatments.
• This approach overcomes limitations of bulk-tissue analyses.